Degussa health division sales up 14% in 1997:
This article was originally published in Clinica
Executive Summary
Sales in Degussa's health and nutrition division rose 14% to DM3.1 billion ($1.7 billion) in the year ended September 30 1997. The division includes the company's Asta Medica and dental sector. German company Degussa says business development in the dental division was very successful with considerable increases in sales and earnings. In Asta Medica, the foreign business grew satisfactorily, but domestic sales suffered from cost-cutting measures.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.